Peptide receptor radionuclide therapy

Peptide Receptor Radionuclide Therapy (PRRT) is a targeted cancer treatment that delivers radioactive materials directly to tumors. It uses specialized molecules called peptides, which bind specifically to receptors on cancer cells, guiding the radioactive substance precisely where needed. This approach minimizes damage to healthy tissue while effectively destroying cancer cells. PRRT is commonly used for certain types of neuroendocrine tumors and offers a promising option for patients with inoperable or advanced cancers, leveraging the body's own biology to improve treatment specificity and outcomes.